Endocrine and Metabolic Disorders

Endocrine and metabolic diseases span a vast range of conditions. Together, they affect many millions of Americans and can profoundly decrease quality of life. NIDDK supports research on many of these conditions, including osteoporosis, cystic fibrosis, hypothyroidism, and obesity. Osteoporosis is a disease marked by reduced bone strength and linked to aging and fracture risk. 53 million people in the United States either have or are at risk for osteoporosis. Hypothyroidism, or underactive thyroid, affects about 4.6 percent of the U.S. population age 12 and older. More than 30,000 Americans have cystic fibrosis, an inherited disease in which salt and water cannot flow appropriately in many critical tissues. Despite dramatic advances in treatment and life expectancy, cystic fibrosis substantially reduces lifespan and its management is challenging.

      Related Conference of Endocrine and Metabolic Disorders

      November 24-25, 2025

      6th International conference on Diabetic complications

      Barcelona, Spain
      February 09-10, 2026

      20th International Conference on Endocrinology, Diabetes and Metabolism

      Singapore City, Singapore
      February 12-13, 2026

      5th Global Summit on Physiology and Metabolism of Thyroid

      Singapore City, Singapore
      February 23-24, 2026

      19th International Summit on Diabetes

      London, UK
      February 25-26, 2026

      16th World Congress on Endocrinology and Diabetes

      Paris, France
      March 26-27, 2026

      7th Global summit on Diabetes and Endocrinology

      Amsterdam, Netherlands
      May 14-15, 2026

      7th World Summit on Diabetes

      Rome, Italy
      May 18-19, 2026

      57th Annual Congress on Endocrinology and Diabetes Research

      Aix-en-Provence, France

      Endocrine and Metabolic Disorders Conference Speakers

        Recommended Sessions

        Related Journals

        Are you interested in